Allergy Therapeutics plc (LON:AGY - Get Free Report) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 7.20 ($0.10) and traded as high as GBX 8.10 ($0.11). Allergy Therapeutics shares last traded at GBX 8.10 ($0.11), with a volume of 260,751 shares traded.
Allergy Therapeutics Trading Down 1.2%
The company has a market cap of £393.21 million, a price-to-earnings ratio of -7.71, a price-to-earnings-growth ratio of -30.70 and a beta of 1.40. The company has a debt-to-equity ratio of 835.48, a current ratio of 1.63 and a quick ratio of 1.48. The business has a 50 day simple moving average of GBX 7.20 and a 200 day simple moving average of GBX 6.77.
About Allergy Therapeutics
(
Get Free Report)
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Read More
Before you consider Allergy Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allergy Therapeutics wasn't on the list.
While Allergy Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
